Literature DB >> 20484877

Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.

T Wetzig1, M Woitek, K Eichhorn, J C Simon, U Paasch.   

Abstract

BACKGROUND: The incidence of skin cancer and especially basal cell carcinoma (BCC) has increased in the last few decades. The gold standard of care is usually a surgical excision, but it also has the risk of local recurrence depending on tumor characteristics.
OBJECTIVES: We analyzed the 5-year cure rates after surgical excision of BCC with complete margin control using paraffin-embedded sections.
METHODS: A retrospective analysis of 671 patients (45.3% male, 54.7% female) with 777 primary and 85 with recurrent BCC were collected during 2001-2003. All patients underwent surgery with complete margin control using paraffin-embedded sections. When the histological examination revealed a positive margin, another surgical step was performed in the area of residual tumor.
RESULTS: Five-year follow-up examinations were possible in 630/862 (73.1%) of patients with BCC. In the group with primary BCC (n = 562), 3 tumor recurrences (0.5%) were identified; in the group with recurrent BCC (n = 68), 2 tumor recurrences (2.9%) were seen, resulting in an overall 5-year recurrence rate of 0.8% for all patients with BCC. The mean tumor recurrence time after surgery was 36.6 months.
CONCLUSION: Local complete tumor resection confirmed by complete margin control using paraffin-embedded sections can achieve excellent cure rates for both primary and recurrent BCC. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20484877     DOI: 10.1159/000300116

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  6 in total

1.  Nanoelectroablation therapy for murine basal cell carcinoma.

Authors:  Richard Nuccitelli; Saleh Sheikh; Kevin Tran; Brian Athos; Mark Kreis; Pamela Nuccitelli; Kris S Chang; Ervin H Epstein; Jean Y Tang
Journal:  Biochem Biophys Res Commun       Date:  2012-07-04       Impact factor: 3.575

2.  Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids.

Authors:  Verena Prokosch; Solon Thanos; Kristina Spaniol; Tobias Stupp
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-01       Impact factor: 3.117

Review 3.  Surgical treatment of basal cell carcinoma: an algorithm based on the literature.

Authors:  Flávio Barbosa Luz; Camila Ferron; Gilberto Perez Cardoso
Journal:  An Bras Dermatol       Date:  2015-06-01       Impact factor: 1.896

4.  Analysis of effectiveness of a surgical treatment algorithm for basal cell carcinoma.

Authors:  Flávio Barbosa Luz; Camila Ferron; Gilberto Perez Cardoso
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

Review 5.  A Review of Black Salve: Cancer Specificity, Cure, and Cosmesis.

Authors:  Andrew Croaker; Graham J King; John H Pyne; Shailendra Anoopkumar-Dukie; Lei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-26       Impact factor: 2.629

6.  [The role of the micrographic surgery in the management of basal cell carcinoma: experience in the Department of Dermatology, at the Hassan II University Hospital, Fes, Morocco].

Authors:  Salim Gallouj; Niema Aqil; Taoufiq Harmouch; Fatima Zahra Mernissi
Journal:  Pan Afr Med J       Date:  2019-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.